Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists.
- Published In:
- Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(3), 239-56 (2015)
- Authors:
- Uccellatore, Annachiara, Genovese, Stefano, Dicembrini, Ilaria, Mannucci, Edoardo, Ceriello, Antonio
- Database ID:
- RPEP-02816
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02816APA
Uccellatore, Annachiara; Genovese, Stefano; Dicembrini, Ilaria; Mannucci, Edoardo; Ceriello, Antonio. (2015). Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 6(3), 239-56. https://doi.org/10.1007/s13300-015-0127-x
MLA
Uccellatore, Annachiara, et al. "Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists.." Diabetes therapy : research, 2015. https://doi.org/10.1007/s13300-015-0127-x
RethinkPeptides
RethinkPeptides Research Database. "Comparison Review of Short-Acting and Long-Acting Glucagon-l..." RPEP-02816. Retrieved from https://rethinkpeptides.com/research/uccellatore-2015-comparison-review-of-shortacting
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.